Manufacturers Life Insurance Company, The Seres Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$103 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.93 - $2.15 $19,806 - $45,788	-21,297 Reduced 53.33%	18,639 $26,000
Q2 2023 Aug 11, 2023	BUY	$4.67 - $6.55 $52,813 - $74,073	11,309 Added 39.5%	39,936 $191,000
Q4 2022 Aug 11, 2023	SELL	$5.09 - $9.05 $13,676 - $24,317	-2,687 Reduced 8.58%	28,627 $160,000
Q4 2022 Feb 13, 2023	SELL	$5.09 - $9.05 $13,676 - $24,317	-2,687 Reduced 8.58%	28,627 $160,000
Q3 2022 Aug 11, 2023	SELL	$3.5 - $7.2 $4,123 - $8,481	-1,178 Reduced 3.63%	31,314 $201,000

Q3 2022 Nov 03, 2022	SELL	$3.5 - $7.2 $4,123 - $8,481	-1,178 Reduced 3.63%	31,314 $201,000
Q2 2022 Aug 11, 2023	BUY	$2.7 - $7.62 $6,793 - $19,171	2,516 Added 8.39%	32,492 $111,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $6,793 - $19,171	2,516 Added 8.39%	32,492 $111,000
Q1 2022 Aug 11, 2023	BUY	$6.3 - $8.84 $8,498 - $11,925	1,349 Added 4.71%	29,976 $213,000
Q1 2022 May 20, 2022	SELL	$6.3 - $8.84 $44,389 - $62,286	-7,046 Reduced 19.03%	29,976 $213,000
Q4 2021 Feb 16, 2022	SELL	$6.02 - $11.43 $5,725 - $10,869	-951 Reduced 2.5%	37,022 $308,000
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $8,108 - $33,561	-1,485 Reduced 3.76%	37,973 $264,000
Q2 2021 Aug 12, 2021	BUY	$18.46 - $24.36 $147,292 - $194,368	7,979 Added 25.35%	39,458 $941,000
Q1 2021 May 03, 2021	SELL	$17.66 - $28.92 $31,876 - $52,200	-1,805 Reduced 5.42%	31,479 $648,000
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $62,170 - $100,890	2,674 Added 8.74%	33,284 $815,000
Q3 2020 Nov 09, 2020	BUY	$3.74 - $28.74 $9,170 - $70,470	2,452 Added 8.71%	30,610 $867,000
Q2 2020 Aug 10, 2020	BUY	$3.04 - $6.2 $3,748 - $7,644	1,233 Added 4.58%	28,158 $131,000
Q1 2020 May 15, 2020	BUY	$2.64 - $3.82 $4,757 - $6,883	1,802 Added 7.17%	26,925 $96,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $3,593 - $5,312	1,202 Added 5.02%	25,123 $87,000
Q3 2019 Nov 12, 2019	BUY	$2.29 - $4.16 $54,779 - $99,511	23,921 New	23,921 $94,000
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $146,182 - $184,073	-19,943 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $14,469 - $19,997	2,094 Added 11.73%	19,943 $171,000
Q1 2018 May 15, 2018	BUY	$7.34 - $11.16 $1,247 - $1,897	170 Added 0.96%	17,849 $130,000
Q4 2017 Feb 08, 2018	BUY	$9.15 - $12.64 $5,828 - $8,051	637 Added 3.74%	17,679 $178,000
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $218,308 - $287,157	17,042	17,042 $273,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$16.6 Million
1.17% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$4.91 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.73M
Shares

$4.85 Million
0.0% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

5.43M
Shares

$3.91 Million
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

2.13M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account